cihr’s university delegates meeting june 4 th, 2009 dr. alain beaudet, president

28
CIHR’s University Delegates Meeting June 4 th , 2009 Dr. Alain Beaudet, President

Upload: dexter-chesser

Post on 15-Dec-2015

228 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

CIHR’s University Delegates Meeting June 4th, 2009

Dr. Alain Beaudet, President

Page 2: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Discussion Points

Canada’s Health Research landscape

A Health Research Roadmap for 2009-2014

What Canada’s Research Community is saying

Page 3: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Portfolio of CIHR Expenditures ($Millions Including NCE, CERC and CRC)

1999-2000$310M

OperatingExpenditures

$14

NCE$21

Open Competitions

$251

2008-2009$979MOperating

Expenditures $47

StrategicInitiatives

$229

CECR $74

NCE$28

CRC$86

Open Competitions

$510

StrategicInitiatives

$24

Page 4: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Total research expenditures

Gross domestic expenditures on R&D in the health field, by funder, 2007

Federal21%

Provincial6%

Business24%

Higher Ed28%

Non-profit8%

Foreign13%

Total: $6.3 billion

Source: Statistics Canada

Page 5: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Number of Researchers & Trainees Supported by CIHR

5,3706,004

7,7188,882

9,593 9,90211,036 11,478 11,716

0

2,000

4,000

6,000

8,000

10,000

12,000

1999-00 2000-01 2001-02 2002-03 2003-04 2004-05 2005-06 2006-07 2007-08

Fiscal Year

Nu

mb

er o

f H

ealt

h R

esea

rch

ers

and

Tra

inee

s

Page 6: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Average Size of Grants & Awards

$81$92 $95

$103 $106 $109 $111 $112$119

0

20

40

60

80

100

120

1999-00 2000-01 2001-02 2002-03 2003-04 2004-05 2005-06 2006-07 2007-08

Fiscal Year

Ave

rag

e V

alu

e o

f an

Op

en O

per

atin

g G

ran

t (T

ho

usa

nd

s o

f $)

Page 7: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

CIHR Expenditure Forecast

Page 8: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Budget 2009:Strategic Review

2009/10 2010/11 2011/12 On-Going

Open Team Grants Program $1.5M $5.5M $27.6M $27.6M

Indirect Cost of Research $0.4M $1.3M $6.6M $6.6M

Intellectual Property Mobilization Program

-- $2.0M $2.0M $2.0M

Total $1.9M $8.8M $36.2M $36.2M

CIHR was one of the 21 Government departments and agencies that had to undergo a Strategic Review of programs and services. The resulting reallocations were as follows:

Page 9: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Federal Investments in Research

Direct Research Costs in Federal Funding for the Higher Education Sector

30.0%

40.0%

50.0%

60.0%

70.0%

1997-98

1998-99

1999-00

2000-01

2001-02

2002-03

2003-04

2004-05

2005-06

2006-07

Other Programs in Federal Funding for the Higher Education Sector

0.0%

10.0%

20.0%

30.0%

1997-98

1998-99

1999-00

2000-01

2001-02

2002-03

2003-04

2004-05

2005-06

2006-07

People

Infrastructure

Networks

Admin

Page 10: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

A Health Research Roadmapfor creating innovative research and applied knowledge

CIHR’s Five Year Strategic Plan2009-2014

Page 11: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

CIHR’s Proposed Strategic Directions and alignment with S&T Strategy

Four strategic directions to address health challenges:

1. Invest in World-Class Excellence

2. Set Health and Health System Research Priorities

3. Accelerate the Capture of Health and Economic Benefits of Health Research

4. Achieve Organizational Excellence, Foster a Culture of Ethics and Demonstrate Impact

Promoting world-class excellence

Focusing on prioritiesEncouraging partnerships

S&T Strategy Principles

Enhancing accountability

Page 12: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Strategic Direction 1: Invest in World-Class Excellence

Training, retaining and sustaining a healthy research foundation

Providing capacity to attract and retain best researchers

Breaking professional sectorial barriers in health research

Preparing young researchers for various labour markets.

Selecting and sustaining research excellence

Strengthening peer review quality in each of the four health research pillars

Improving the breath and quality of its peer review panels

Promoting interdisciplinary and international innovation

Promoting international collaboration and Canadian leadership of international health research consortia

Facilitating health research capacity-building in low- and middle-income countries

Page 13: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Strategic Direction 2: Set health and health system research priorities

Promote patient-oriented research & target science and technology innovations to improve health outcomes and health systems

Support a high quality, accessible & sustainable health care system

Decrease health inequities in Aboriginal Peoples & other vulnerable populations

Prepare & respond to existing & emerging global threats to health

Promote health & reduce the burden of chronic disease & mental illness

Page 14: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Barriers to Clinical & Translational Research (Valleys of Death)

Valley 1 Valley 2

Basic Biomedical Research

Clinical Science & Knowledge

Clinical Practice &

Health Decision Making

Translational Continuum

Page 15: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Translating Science into Practice and Policy

Source: from Mental Health Workshop, Montreal, April 21-22, 2009

Basic / Translational

Treatment Development

Efficacy

Effectiveness

Implementation / Demonstration

Policy / Dissemination

Mechanisms: underlying processes of diseases and treatments

Testing: methods, safety, dosing

Validity: rigorous methods and measures

Generalizability: diversity of patients, providers, settings

Practicality: barriers and strategies at multiple levels, clinical systems

Relevance: Are institutions/policies changing? Is there uptake? Can it be sustained? Are we making a difference?

Page 16: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Strategy on Patient-oriented Research:Key objectives

• Introduce a culture of knowledge-based care at all levels of the health system

• Improve patient care through rigorous evaluation of new and existing health interventions

• Ensure our international competitiveness in patient-oriented research by building upon existing strengths

• Take better advantage of our universal health system and our administrative databases to monitor outcomes and test ideas

• Develop clinical research programs in areas of greatest need including primary care and mental health

• Fill gaps in Canada’s research infrastructure and human resources (research capacity)

Page 17: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

PORS: A 10-year implementation plan

• Coordinate national programs• Structural model designed for optimal results

• Build capacity and develop clinical research career paths• Training grants • Salary awards programs

• Develop state of the art research infrastructure• The cornerstone: Patient-oriented research support units

• Build thematic clinical research networks Coordinate thematic research units• Ensure development and implementation of Standard Operating

Procedures

• Ensure accountability to stakeholders• Local hospitals / health authorities• Provincial Health Research Organizations and MOH

Page 18: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Strategic Direction 3: Accelerate the capture of health & economic

benefits of health research

CIHR will achieve impacts through effective collaborations & by:

building innovative partnerships (eg. between researchers and knowledge users)

supporting evidence-based health and health system policy at all levels of government;

implementing citizen engagement initiatives; and,

facilitating commercialization.

CIHR will Intensifying knowledge translation research by:

advancing the application of research and its evaluation;

building capacity of both researchers and knowledge users to engage in KT; and,

increasing the number of researchers to advance the science of KT.

Page 19: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

CIHR will ensure transparency and accountability by: developing state-of-the-art human resource management practices;

applying technology-based solutions across the organization;

evaluating the overall success of CIHR; and,

developing an annual implementation delivery plan.

CIHR will foster a culture of ethics by: fostering the discussion and application of ethical principles for health research.

CIHR will assess progress and impact through: its Impact Assessment Framework and its 5 identified criteria: (1) advance

knowledge (2) build capacity (3) inform decision-making (4) improve health and health system, and (5) contribute to the economy.

Strategic Direction 4:Achieve Organizational Excellence, Foster a

Culture of Ethics and Demonstrate Impact

Page 20: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

CIHR Strategic Plan Consultations

• Web-based survey launched on April 30, 2009 (closes June 12)

• Consultations broadcasted via CIHR’s e-blast & e-mail notification to CIHR researchers

• Invited written submissions from over 60 organizations (e.g. charities, research funders, other partners)

• Scientific Council / IAB meetings

• President’s Roundtables:• Toronto• Vancouver• St-John’s• Montreal• London• Saskatoon• Quebec City• Edmonton• Calgary• Winnipeg• Halifax

• Additional consultations with stakeholders (e.g. ACAHO, AFMC, RCPSC)

Page 21: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Preliminary Results from National Survey

• Over 330 completed surveys (2 weeks)

• Majority of participants were from:

Ontario (37%),

Quebec (27%) and

Alberta (12%)

• The majority of participants came from the academic sector (71%). Of the participants that come from a university setting, 38% identified as full professors, 23% associate professors and 14% graduate students.

Page 22: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Survey Respondents/Pillar representation

2%3%

25%22%

27%

56%

0

10

20

30

40

50

60

Pillar 1 Pillar 2 Pillar 3 Pillar 4 None of theabove

prefer not tosay

per

cen

tag

e

Page 23: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Survey Respondents / Career Stage

Early26%

Mid19%

Senior 54%

Prefer not to say 1%

Page 24: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

27%

36%

24%

30%

34%

22%

30%

26%

30%

53%

57%

52%

63%

53%

50%

60%

56%

48%

13%

15%

5%

9%

19%

6%

11%

16%

4%

5%

5%

4%

4%

4%

6%

3%

1%

3%

1%

1%

4%

2%

3%

3%

0% 20% 40% 60% 80% 100%

Total

Female

Male

Healthsystems/services

Clinical

Biomedical

Soc. cultural/enviro/pop. health

University/college

Other

Overall Support for the Strategic Plan

27%

25%

21%

26%

35%

20%

20%

29%

19%

30%

53%

53%

57%

48%

52%

70%

80%

66%

55%

47%

13%

9%

14%

19%

8%

16%

16%

4%

4%

6%

6%

5%

5%

5%

5%2%

2%

3%

3%

2%

1%

2%

4%

9%

3%

0% 20% 40% 60% 80% 100%

Total

BC

Praries (AB/SK/MN)

ON

QC

East

Outside Can.

Early career

Mid career

Senior

Strongly support Support Oppose Strongly oppose No opinion

Please indicate your level of overall support for CIHR’s five year strategic plan.

Page 25: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Preliminary Results Web Survey Results

• Strategic Plan received endorsement of 80% of participants (strongly support and support)

• Four strategic directions received support ranging from:• 94%-77% for Strategic Direction 1 – World class excellence• 77% for Strategic Direction 2 – Health system priorities • 77%-73% for Strategic Direction 3 – Knowledge Translation• 81% for Strategic Direction 4 – Organisational Excellence

• Open ended questions have yet to be fully analysed

Page 26: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Preliminary Results from Web Survey

• Most contentious issues were:

• Section on intensifying KT (Strategic Direction 3) (23% opposed):Comments received noted that too much emphasis was given to commercialization and knowledge transfer and some stressed that CIHR should focus solely on encouraging research and let those interested in commercialization find other resources.

• International Collaborations (Strategic Direction 1) (18% opposed): Comments received noted that the focus on international is ultimately positive but our domestic research agenda needs to be solidified before taking-on international efforts.

• Research Priorities (Strategic Direction 2) (18% opposed):Comments received noted that we cannot make top-down decisions about what will be important areas of research.

Page 27: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Common areas of interest: noted through visits and web-survey

• Basic Science: Misperceptions noted in consultations that CIHR is moving away from supporting basic science while providing too much emphasis on the other three pillars.

• Post-Doctoral/Fellowship support: Comments received noted inconsistencies in Canada with the financial support and taxation regulations between post-doctoral and fellowships.

• Large-scale projects: Comments received noted concerns with the impacts of some of the large-scale projects (e.g. SPOR and Alzheimer’s project) on A-base funding.

• Teaching hospitals: Research hospitals play a central role in health research but not present in plan. CIHR leadership being sought at this level as teaching/research hospitals struggle to make their research role recognized at the provincial level.

• Peer-review: Comments received in consultations noted a number of problems with peer-review that include a need for change of culture, peer-review fatigue and inconsistencies across Canada in peer-review activities.

• CIHR Branding: Strong interest by researchers, students and stakeholders to communicate with decision-makers regarding the importance of health research for Canada.

Page 28: CIHR’s University Delegates Meeting June 4 th, 2009 Dr. Alain Beaudet, President

Next Steps

• Web consultations ends June 12, 2009;

• Summary feedback report will be posted on CIHR’s website;

• Recommendations for changes to final Research Roadmap will be presented to CIHR’s Governing Council;

• Scientific Directors will provide assistance with the development of Implementation Plan; and,

• Roadmap will be launched in fall 2009.